Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.760
+0.020 (1.15%)
At close: Sep 5, 2025, 4:00 PM
1.780
+0.020 (1.14%)
After-hours: Sep 5, 2025, 7:54 PM EDT
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $63.27 million as of September 5, 2025. Its market cap has increased by 69.71% in one year.
Market Cap
63.27M
Enterprise Value
57.26M
1-Year Change
69.71%
Ranking
Category
Stock Price
$1.76
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $63.27M, a decrease of -49.24%. That is a compound annual growth rate of -14.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 60.15M | 4.99% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
| Mar 18, 2021 | 124.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |